Pegcetacoplan (Syfovre) for Geographic Atrophy: A Patient’s Journey at the ELZA Institute
At the ELZA Institute in Zurich, patients with geographic atrophy (GA), an advanced form of age-related macular degeneration (AMD), now have access to cutting-edge treatments, including pegcetacoplan, marketed as Syfovre. GA can severely impact vision, making everyday tasks challenging. One of our patients shared their remarkable experience with Syfovre and how it transformed their quality of life.
After returning from a trip to Africa, they realized they could no longer read their diary—a moment that sparked concern. “I was shocked,” they recalled. “After visiting several doctors, I was told nothing could be done and that it was simply age-related macular degeneration.” However, hope arrived in an unexpected way.
“I actually heard about the ELZA Institute from my cigar dealer,” they laughed. “And Syfovre? I just Googled it and saw it was from America and very expensive.” Despite their initial skepticism, they decided to explore the treatment further.
At ELZA, Dr. M. Enes Aydemir and Dr. Andrea Oleñik provided a thorough assessment and recommended Syfovre injections to slow the progression of GA. Initially apprehensive about an eye injection, the patient was pleasantly surprised by the experience. “I thought a syringe in the eye would be terrifying, but the preparation by the doctors and nurses was so professional that I didn’t feel a thing—except a slight burn when the needle was removed, which only lasted five minutes.”
Following treatment, the patient’s vision improved significantly. “I sometimes don’t dare to believe it myself, but I can now read an entire newspaper without a magnifying glass!” They even expressed optimism about regaining their driver’s license. “It feels like a huge improvement, and I can’t believe how much better my vision has become.”
This inspiring journey underscores the potential of Syfovre in managing geographic atrophy and highlights ELZA Institute’s commitment to delivering state-of-the-art, patient-centered ophthalmic care.
If you or a loved one are experiencing vision challenges due to geographic atrophy, why not contact the ELZA Institute to learn about the latest treatment options.
